Lysis and Beyond: ESC Guidelines and Reality J N Townend Queen Elizabeth Hospital Birmingham.

Slides:



Advertisements
Similar presentations
Patient Oriented Therapy for STE-MI
Advertisements

STREAM 1Y AHA 2013 P Sinnaeve STREAM - ONE YEAR MORTALITY STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION.
A Pharmaco-invasive Reperfusion Strategy with Immediate Percutaneous Coronary Intervention is Safe and Effective in ST-Elevation Myocardial Infarction.
NO CONFLICT OF INTEREST TO DECLARE J.M. McLENACHAN, LEEDS.
Optimal Timing of PCI in ACS Patrick Hildbrand. Trends and Prognosis in ACS Furman MI, JACC 2001, 37: Hospital 1 year.
Regional Systems of Care to Optimize Timeliness of Reperfusion Therapy for STEMI: The Mayo Clinic Protocol Henry H. Ting, MD, MBA Associate Professor of.
Utilization of Rescue and Facilitated Angioplasty for Primary PCI: Who Should Get Lytic Therapy in 2009? Adnan Kastrati Deutsches Herzzentrum, Technische.
PPCI – National Update NCBC Workshop Jim McLenachan, National Clinical Lead for PPCI, NHS Improvement, England. London, 24 th November, NCBC Annual.
on behalf of the TOTAL Investigators
Perspective on COMMIT/CCS-2 Trial of Metoprolol in STEMI Christopher Cannon, M.D. Brigham and Women’s Hospital Boston, MA.
Improved Care for Acute Myocardial Infarction Linking Referral and Receiving Centres – How can We Communicate Better? Dr. James McMeekin AMI Faculty Cardiologist,
Clinical Trial Results. org Rescue Angioplasty or Repeat Fibrinolysis After Failed Fibrinolytic Therapy for ST-Segment Myocardial Infarction: A Meta-Analysis.
Primary PCI Treatment of choice for Acute MI.
Professor Roger Boyle CBE National Director for Heart Disease and Stroke Department of Health PCI in the UK: Fit for service? A view from the Department.
Interventional Registries The Audit and Research Potential of the BCIS CCAD Registry Peter F Ludman.
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
GP IIb/IIIa Inhibition in STEMI: Growing Clinical Trial Evidence.
Ten Points to Remember from the 2007 STEMI Guideline Update Based on the 2007 Focused Update of the 2004 Guidelines for the Management of Patients With.
Welcome Ask The Experts March 24-27, 2007 New Orleans, LA.
ACS and Thrombosis in the Emergency Setting
Partner meeting Aprile, Alberto Cremonesi.
MD DM DNB FACC FICC FCSI FESC LAKSHMI HOSPITAL, PALAKKAD.
Advanced Cardiovascular Intervention 2009 Timings in PPCI: Have we learnt the lessons from our European Colleagues? Peter F Ludman.
A modern thrombolysis service is superior to primary angioplasty
Prehospital Fibrinolysis with Double Antiplatelet Therapy in Acute ST-Elevation Myocardial Infarction: The Clarity Ambulance Substudy Prehospital Fibrinolysis.
” “The Dissociation Between Door-to- Balloon Time Improvement and Improvements in Other Acute Myocardial Infarction Care Processes and Patient Outcomes”
1 Primary Angioplasty for Acute STEMI Dr Adam Jacques Dr Sola Odemuyiwa February 2010.
Role of Percutaneous coronary intervention (PCI) after thrombolytic therapy By Dr. Mohamed Mahros Assistant lecturer of cardiology Benha faculty of medicine.
Management Of AMI Does time matter?? What is the best strategy: PPCI Vs TT.
Which Early ST-Elevation Myocardial Infarction Therapy (WEST) Trial Paul W. Armstrong, WEST Steering Committee Published in The European Heart Journal.
Myocardial Ischaemia National Audit Project Are we replacing good fibrinolytic treatment with poor primary PCI? John Birkhead who has NO CONFLICT OF INTEREST.
Advanced Angioplasty 2005 Primary PCI making it happen Data collection and Timings Peter Ludman University Hospital Birmingham.
Rescue Angioplasty versus Conservative Therapy or Repeat Thrombolysis Trial Presented at American Heart Association Scientific Sessions 2004 Presented.
Delays in Fibrinolytic Administration for Acute ST-Segment Elevation Myocardial Infarction: Results from the Acute Coronary Treatment and Interventions.
AA 2008 Session III: STEMI The UK data Mark de Belder The James Cook University Hospital Middlesbrough.
Acute Coronary Syndromes SIGN 93. MINAP Mortality after Acute Coronary Syndromes Cumulative: 13.6% Blue 10.6% Green 11.6% Red.
West Hertfordshire Primary Angioplasty Service Masood Khan.
TACTICS- TIMI 18 Treat Angina with Aggrastat TM and Determine Cost of Therapy with an Invasive or Conservative Strategy.
Acute Coronary Syndromes Risk-Stratification Pathophysiology Diagnosis Initial Therapy Risk-Stratification Risk-Stratification Invasive vs Conservative.
Inter-Hospital Transfer of High Risk STEMI Patients for PCI is Safe and Feasible David M. Larson, Katie M. Menssen, Scott W. Sharkey, Marc C. Newell, Anil.
Door to Balloon Time: Does it Matter? Tale of Two Studies.
Dr Martyn Thomas Kings College Hospital Primary angioplasty “A UK Experience” “The UK experience”
IABP用于高危PCI有价值吗? Is IABP Valuable for High-Risk PCI?
Agrément FMC N° Conflits d’intérêt Astra-Zeneca, BMS, MSD, Novartis, Pfizer, Daiichi-Sankyo, Servier, CRAM, AFSSAPS, ARH Région de Bourgogne Clos.
Transfers, Facilitated and Rescue PCI for AMI Michael J Cowley, M.D., FSCAI Nothing to disclose.
Date of download: 6/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2007 Focused Update of the ACC/AHA 2004 Guidelines.
High-risk ST elevation MI patients (>4 mm elevation), Sx < 12 hrs 5 PCI centers (n=443) and 22 referring hospitals (n=1,129), transfer in < 3 hrs High-risk.
SPEED : GUSTO-IV PILOT GUSTO-IV Pilot Trial. SPEED : GUSTO-IV PILOT Rationale for Combination Therapy in AMI Enhance Incidence and Speed of Reperfusion.
MINAP: MINAP: Equity of Access in the National Databases in Wales? Swansea University/ABMU, NICOR Swansea University/ABMU,
an open, prospective, randomized, multicentre trial
Direct catheter-based thrombectomy in acute ischemic stroke
PRAGUE-18 Trial design: Patients with STEMI undergoing primary PCI were randomized to prasugrel (n = 634) versus ticagrelor (n = 596). Results (p = 0.94)
STEMI-INITIAL PRESENTATION TIMING 2013 ACC/AHA GUIDELINES
Angiography-guided PCI
European Society of Cardiology 2003
Date: Presenter: Ryan Chen
Figure 1 PCI strategies in patients with STEMI and multivessel disease
Published in the European Heart Journal
Primary PCI Monitoring Performance
Primary PCI Monitoring Performance
TIMI IIIA Protocol Design 391 Patients with Unstable Angina / NQWMI
American College of Cardiology Presented by Dr. Michel R. Le May
RIDDLE-NSTEMI Trial design: Patients with NSTEMI were randomized to either immediate (within 2 hours) intervention or delayed (within 72 hours) intervention.
Global Registry of Acute Coronary Events: GRACE
What oral antiplatelet therapy would you choose?
Maintenance of Long-Term Clinical Benefit with
European Heart Journal Advance Access
Management of AMI in patients presenting with STEMI
IMPRESS Trial design: Patients undergoing primary PCI for STEMI and cardiogenic shock were randomized in a 1:1 to either Impella CP or IABP. They were.
16-year follow-up of the DANish Acute Myocardial Infarction 2 (DANAMI-2) trial PG Thranea, SD Kristensena, KKW Olesena, LS Mortensenb, HE Bøtkera, L.
Presentation transcript:

Lysis and Beyond: ESC Guidelines and Reality J N Townend Queen Elizabeth Hospital Birmingham

NO CONFLICT OF INTEREST TO DECLARE

Lytic Therapy: Class I recommendation when PPCI cannot be performed within 2 hours (or 90 minutes) NB must be <90 mins if present early with a large amount of viable myocardium

Lytic Therapy: Not Yet Redundant in the UK

PPCI and Lysis for STEMI : The View from the Clent Hills Lytic therapy PPCI for some in 2010 The long term ? PPCI West: Herefordshire, Worcestershire, Wales North East: Birmingham & West Midlands

Beyond Lysis: ESC Guidelines The pharmaco-invasive strategy: –“Rescue PCI should be considered when there is evidence of failed fibrinolysis…or if there is uncertainty” Class IIa recommendation, level of evidence B –“If it is likely that fibrinolysis was successful angiography is recommended… time window of 3-24 hours” Class IIa recommendation, level of evidence A

Rescue PCI: REACT Rescue PCI vs. repeat lytic vs. conservative therapy for failed 90 mins N = 427 Primary end point: –Death, re-MI, CVA,CHF reduced by >50% Mortality reduced by 50% Gershlick et al. NEJM 2005

How Often is Rescue PCI Required? CAPTIM(n=419)26% CARESS-in-AMI (n=300)30% TRANSFER AMI (n=522)34%? At least 1 in 4 cases

Trials demonstrating efficacy of routine early angiography and PCI after STEMI Trial DateN SIAM III GRACIA CAPITAL AMI CARESS-in -AMI TRANSFER-AMI NORDISTEMI

RR = 0.64, p=0.004 Death, re-MI, CHF, shock Days from randomization

PCI Rate after Lytic Therapy PCI rates in studies of routine post lytic angiography/PCI after STEMI: GRACIA 180% CARESS86% TRANSFER AMI85% FAST MI registry84%

According to treatmentPropensity matched Circulation 2008

How to Avoid Bleeding Associated with PCI Following Lytic Therapy

REALITY Angiography and PCI rates following lytic therapy in cases in 2008 in England and Wales MINAP: data on STEMI cases from all acute hospitals in England and Wales BCIS: data on (almost) all UK centres performing PCI –Rescue PCI –PCI within one month of lytic therapy

Rescue 14% Protocol driven 20% Not performed 32% Angiography rate after STEMI = 62% Reality according to MINAP: Angiography Rates in England and Wales after Lytic Therapy in 2008 Symptom driven 21% Post discharge 7%Unclear 4%Indication unclear 2% N=12297

Interval: Admission to Angiography STEMI admitted to Interventional Hospitals

Reality according to BCIS: PCI Rates after Lytic Therapy in 2008 Rescue = 18% Recent lytic therapy 22% The rest - No PCI(?) = 60% England and Wales PCI rate early after STEMI was 40% N=12297

In Conclusion In England and Wales, rescue PCI performance is quite good (about 70% predicted) The rest of post STEMI invasive angiographic / interventional care for lytic treated patients is too little and too late Could do better

Admission to a non-PCI Centre After Lytic Therapy : Wrong Place, Wrong Time